MBL77 - AN OVERVIEW

mutations presented the fact that, as discussed below, CLL therapy relies on the existence or absence of those mutations. The existing consensus is that, other than clonal mutations, subclonal mutations that has a variant allelic frequency ranging from five to 10% (and thus under the threshold of detection by standard molecular procedures) could al